`
`
`
`
`
`
`
`
`Paper No. ___
`Filed: August 18, 2017
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`_____________________________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`_____________________________
`
`
`APOTEX INC., APOTEX CORP., and
`ARGENTUM PHARMACEUTICALS LLC,
`Petitioners,
`
`v.
`
`NOVARTIS A.G.,
`Patent Owner.
`
`_____________________________
`
`Case IPR2017-008541
`Patent No. 9,187,405
`
`_____________________________
`
`
`PETITIONERS’ NOTICE OF OBJECTIONS TO EVIDENCE
`
`
`1 Case IPR2017-01550 has been joined with this proceeding.
`
`
`
`
`
`
`Case IPR2017-00854
`Patent 9,187,405
`
`TABLE OF CONTENTS
`
`INTRODUCTION ........................................................................................ 1
`I.
`OBJECTIONS .............................................................................................. 1
`II.
`1.
`Thereon ..................................................................................... 1
`III. CONCLUSION ............................................................................................ 3
`
`Objections to EX3002, and any Reference to/Reliance
`
`
`
`
`-i-
`
`
`
`
`Case IPR2017-00854
`Patent 9,187,405
`I.
`INTRODUCTION
`
`Pursuant to 37 C.F.R. § 42.64(b)(1), Apotex Inc. and Apotex Corp.
`
`(“Petitioner”) submits the following objections to Board Exhibit 3002, filed on
`
`August 11, 2017, and any reference to or reliance on the foregoing Exhibit in
`
`Board papers or future filings by the Board or by Patent Owner. Petitioner’s
`
`objections apply the Federal Rules of Evidence (“F.R.E.”).
`
`II. OBJECTIONS
`
`1. Objections to EX3002, and any Reference to/Reliance Thereon
`
`Grounds for Objection: F.R.E. 106 (Incomplete Record); F.R.E. 401, 402
`
`(Irrelevant Evidence Inadmissible); F.R.E. 403 (Excluding Evidence for Prejudice,
`
`Confusion, Waste of Time, or Other Reasons); F.R.E. 602 (Foundation); F.R.E.
`
`802 (Inadmissible Hearsay); 37 C.F.R. § 42.6(a)(3).
`
`The Board’s Ex. 3002 is a copy of an email sent by Patent Owner to the
`
`Board requesting a conference call regarding scheduling the deposition of
`
`Petitioner’s expert. Patent Owner’s original email to the Board itself attached a
`
`separate email thread between the parties regarding their efforts to schedule the
`
`deposition. In Ex. 3002, the Board fused the Patent Owner’s email to the Board
`
`with the separate email thread between the parties into one document.
`
`Ex. 3002 as it presently stands is prejudicial, lacks foundation, and is
`
`incomplete. Notably, the thread portion contains an email from Patent Owner’s
`
`
`-1-
`
`
`
`Case IPR2017-00854
`Patent 9,187,405
`counsel to Petitioner’s counsel that is a one-sided and inaccurate representation of
`
`a meet-and-confer call the two parties had to try to resolve the scheduling
`
`difficulties. Patent Owner’s email was sent to Petitioner a mere 9 minutes before
`
`the Patent Owner emailed the Board to request the conference call and attached the
`
`thread as a separate document. The thread is incomplete because it does not
`
`contain Petitioner’s subsequent response to the Board which stated “Additionally,
`
`Petitioner finds Patent Owner’s inclusion of self-serving and inaccurate emails
`
`objectionable and unhelpful to advancing a productive conversation on the matter.”
`
`Further, during the ensuing call with the Board on August 10, 2017,
`
`referenced in the Order (paper no. 16), counsel for Patent Owner stated that it had
`
`not provided a court reporter for the call because it considered the conference call
`
`to “be an off-the-record” discussion with the parties. Thus, for the Board to make
`
`the email thread between the parties an Exhibit in the proceeding is inconsistent
`
`with the intent stated by Patent Owner at the time of the call with the Board.
`
`To the extent that the Board or Patent Owner relies on any statements in
`
`EX3002 for the truth of the matter asserted, such statements are inadmissible
`
`hearsay. F.R.E. 801, 802, 803, 805.
`
`-2-
`
`
`
`Case IPR2017-00854
`Patent 9,187,405
`III. CONCLUSION
`
`The aforementioned Exhibit 3002 was filed with the Order on August 11,
`
`2017. These objections are made to Ex. 3002 within 5 business days of said Order,
`
`pursuant to 37 C.F.R. § 42.64(b)(1).
`
`Respectfully submitted,
`
`/ Steven W. Parmelee /
` Steven W. Parmelee, Lead Counsel
` Reg. No. 31,990
`
`
`
`
`
`
`Dated: August 18, 2017
`
`
`
`
`
`
`
`
`
`
`
`
`
`-3-
`
`
`
`Case IPR2017-00854
`Patent 9,187,405
`
`CERTIFICATE OF SERVICE
`
`
`
`This is to certify that I caused to be served a true and correct copy of the
`
`foregoing Petitioners’ Notice of Objections to Evidence, on this 18th day of
`
`August, 2017, on the Patent Owner at the correspondence address of the Patent
`
`Owner as follows:
`
`Jane M. Love, Ph.D.
`Robert W. Trenchard
`GIBSON, DUNN & CRUTCHER LLP
`200 Park Avenue, 47th Floor
`New York, NY 10166
`Email: jlove@gibsondunn.com
`Email: rtrenchard@gibsondunn.com
`
`
`
`
`
`
`
`
`Dated: August 18, 2017
`
`
`
`
`
`
`Respectfully submitted,
`
`/ Steven W. Parmelee /
` Steven W. Parmelee, Lead Counsel
` Reg. No. 31,990
`
`
`
`
`
`-4-
`
`